HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of a new adrenergic beta 2 -receptor-stimulating agent (rimiterol, R798) in patients with chronic obstructive lung disease.

AuthorsN Svedmyr, R Malmberg, G Thiringer
JournalScandinavian journal of respiratory diseases (Scand J Respir Dis) Vol. 53 Issue 5 Pg. 302-13 ( 1972) ISSN: 0036-5572 [Print] Denmark
PMID4404808 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)
Chemical References
  • Adrenergic beta-Agonists
  • Aerosols
  • Amino Alcohols
  • Bronchodilator Agents
  • Catechols
  • Piperidines
  • Placebos
  • rimiterol
  • Isoproterenol
  • Methanol
Topics
  • Adrenergic beta-Agonists (pharmacology, therapeutic use)
  • Adult
  • Aerosols
  • Amino Alcohols (pharmacology, therapeutic use)
  • Bronchi (drug effects)
  • Bronchodilator Agents (administration & dosage, adverse effects, pharmacology, therapeutic use)
  • Catechols (administration & dosage, therapeutic use)
  • Dose-Response Relationship, Drug
  • Heart Rate (drug effects)
  • Humans
  • In Vitro Techniques
  • Infant, Newborn
  • Isoproterenol (pharmacology, therapeutic use)
  • Lung Diseases (drug therapy)
  • Methanol (administration & dosage, therapeutic use)
  • Middle Aged
  • Muscle Contraction (drug effects)
  • Muscle, Smooth (drug effects)
  • Piperidines (administration & dosage, therapeutic use)
  • Placebos
  • Respiration (drug effects)
  • Spirometry
  • Stimulation, Chemical
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: